Management of Abdominal Aortic Aneurysm
Surveillance Strategy Based on Size and Sex
- The European Society of Cardiology recommends duplex ultrasound (DUS) as the primary surveillance modality for abdominal aortic aneurysm (AAA), with surveillance intervals determined by aneurysm diameter and patient sex 1, 2
- For men, the recommended surveillance intervals are: 25-29 mm every 4 years, 30-39 mm every 3 years, 40-49 mm annually, and 50-55 mm every 6 months 1, 2
- For women, the recommended surveillance intervals are: 25-29 mm every 4 years, 30-39 mm every 3 years, 40-44 mm annually, and 45-50 mm every 6 months 1, 2
- Women have a four-fold higher rupture risk than men at similar aneurysm sizes, justifying lower repair thresholds and more aggressive surveillance 1, 3
- If DUS does not allow adequate measurement, cardiovascular CT (CCT) or cardiovascular MRI (CMR) is required 1, 2
- Surveillance intervals should be shortened to every 3-6 months if rapid growth occurs: ≥10 mm per year or ≥5 mm per 6 months 1, 2
Indications for Elective Repair
- The European Society of Cardiology recommends elective repair when AAA diameter reaches ≥55 mm in men or ≥50 mm in women 1, 2, 3
- Additional repair indications include symptomatic AAA, rapid expansion (≥10 mm per year or ≥5 mm per 6 months), and saccular morphology ≥45 mm due to higher rupture risk at smaller sizes 1, 2, 3
- Elective repair is not recommended in patients with limited life expectancy (<2 years) 2, 3
Medical Management: Cardiovascular Risk Reduction is Primary
- Optimal cardiovascular risk management is mandatory for all AAA patients, as the 10-year risk of death from cardiovascular causes is up to 15 times higher than the risk of aorta-related death 1, 2, 3
- Core medical interventions include smoking cessation, intensive lipid management to LDL-C target <1.4 mmol/L (<55 mg/dL), blood pressure control, and single antiplatelet therapy with low-dose aspirin if concomitant coronary artery disease is present 1, 2
Special Considerations for Underlying Conditions
- Fluoroquinolones are generally discouraged for patients with aortic aneurysms but may be considered only if there is a compelling clinical indication with no reasonable alternative 1, 2
Choice of Repair Technique
- Endovascular aneurysm repair (EVAR) is preferred over open repair for most patients with suitable anatomy, reducing peri-operative mortality to <1% compared to 4-5% with open repair 1, 2
- EVAR is recommended over open repair for ruptured AAA with suitable anatomy to reduce peri-operative morbidity and mortality 1, 2
Post-EVAR Surveillance
- Perform 30-day imaging with CCT plus DUS/contrast-enhanced ultrasound to assess intervention success 2, 3
- Follow-up schedule: 1 month and 12 months post-operatively, yearly until fifth post-operative year, and after 5 years, consider CCT or MRI every 5 years if DUS is used for routine surveillance 2
- Re-intervene for type I or type III endoleaks to achieve seal 2, 3
Emergency Management
- For patients presenting with suspected ruptured AAA, immediate surgical evaluation is indicated, with a 75-90% mortality risk 2